← All stocks

Revolution Medicines, Inc.

RVMDBiotechnologyLatest filing used: 2026-11-04Filings on SEC EDGAR ↗

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$172.28

Nov 13, 2026

How we decide

Ten years of results

Revenue

$0 in FY2025

FY2018: $20MFY2019: $50MFY2020: $43MFY2021: $29MFY2022: $35MFY2023: $12MFY2024: $0FY2025: $0$30M$60MFY18FY19FY22FY25$0
Show as table
YearRevenue
FY2018$20M
FY2019$50M
FY2020$43M
FY2021$29M
FY2022$35M
FY2023$12M
FY2024$0
FY2025$0

Shares outstanding

Share count rose 246% over 7 years

FY2020: 55MFY2021: 73MFY2022: 81MFY2023: 113MFY2024: 168MFY2025: 190M0100M200MFY18FY19FY22FY25190.1M
Show as table
YearShares outstanding
FY2018–
FY2019–
FY202055M
FY202173M
FY202281M
FY2023113M
FY2024168M
FY2025190M

No cash earnings in the filings. No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-04. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.